A Phase 1, Open-label Study to Evaluate the Pharmacokinetics of Tralokinumab in Adolescents With Asthma
Phase of Trial: Phase I
Latest Information Update: 08 Mar 2017
At a glance
- Drugs Tralokinumab (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- Sponsors MedImmune
- 09 Jan 2013 Status changed from active, no longer recruiting to completed as reported by European Clinical Trials Database.
- 05 Dec 2012 Planned end date changed from 1 May 2013 to 1 Feb 2013 as reported by ClinicalTrials.gov.
- 05 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.